Changing paradigms in matched platelet support

Transfusion

Volumn 48, Issue 2, 2008, Pages 204-206

  Vassallo, Ralph R ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ALLOIMMUNIZATION; AMINO ACID SEQUENCE; APHERESIS; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

BLOOD PLATELETS; HLA ANTIGENS; HUMANS; PLATELET TRANSFUSION;

EID: 38349138821     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01606.x     Document Type: Editorial

References (18)

1. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004 103 : 333 9.
2. Yankee RA, Grumet FC, Rogentine GN. Platelet transfusion therapy. The selection of compatible donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 1969 281 : 1208 12.
3. Whitaker BI, Sullivan M. The 2005 nationwide blood collection and utilization survey report. Bethesda (MD) : American Association of Blood Banks 2006. p. 21.
4. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977 2 : 219 26.
5. MacPherson BR, Hammond PB, Maniscalco CA. Alloimmunization to public HLA antigens in multitransfused platelet recipients. Ann Clin Lab Sci 1986 16 : 38 44.
6. Rodey GE, Neylan JF, Whelchel JD, Revels KW, Bray RA. Epitope specificity of HLA Class I alloantibodies: I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994 39 : 272 80.
7. Hussain MA, Lee EJ, Fletcher R, Schiffer CA. The effect of lymphocytotoxic antibody reactivity on the results of single antigen mismatched platelet transfusions to alloimmunized patients. Blood 1996 87 : 3959 62.
8. Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000 40 : 1446 56.
9. Nance ST, Hsu S, Vassallo RR, Murphy S. Review: platelet matching for alloimmunized patients - room for improvement. Immunohematology 2004 20 : 80 8.
10. Murphy S, Varma M. Selecting platelets for transfusion of the alloimmunized patient: a review. Immunohematology 1998 14 : 117 23.
11. Rachel JM, Sinor LT, Tawfik OW, Summers TC, Beck ML, Bayer WL, Plapp FV. A solid-phase red cell adherence test for platelet cross-matching. Med Lab Sci 1985 42 : 194 5.
12. Petz LD. The HLA system and platelet transfusion. In : Murphy S, editor. The HLA system: basic biology and clinical applications. Bethesda (MD) : American Association of Blood Banks 1999. p. 133 75.
13. Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 1988 90 : 63 8.
14. Sanz C, Freire C, Alcorta I, Ordinas A, Pereira A. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support. Transfusion 2001 41 : 762 5.
15. Kiefel V, Konig C, Kroll H, Santoso S. Platelet alloantibodies in transfused patients. Transfusion 2001 41 : 766 70.
16. Vassallo RR Jr. New paradigms in the management of alloimmune refractoriness to platelet transfusions. Curr Opin Hematol 2007 14 : 655 63.
17. Duquesnoy RJ. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion 2008 48 : 221 7.
18. Nambiar A, Duquesnoy RJ, Adams S, Zhao Y, Oblitas J, Leitman S, Stroncek D, Marincola F. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood 2006 107 : 1680 7.